Epithalon vs GHK-Cu: Which Anti-Aging Peptide Does What?

Two Anti-Aging Mechanisms, One Research Protocol

Epithalon and GHK-Cu are the two most studied anti-aging peptides in preclinical research — but they work through completely different mechanisms. Understanding the distinction is essential for designing effective longevity research protocols.

The Core Comparison

Feature

Epithalon (AEDG)

GHK-Cu

Type	Tetrapeptide	Copper-binding tripeptide
Primary target	Telomere biology	Extracellular matrix / gene expression
Key mechanism	hTERT upregulation → telomere elongation	300+ gene modulation via copper-dependent signaling
Research depth	40+ years (Khavinson)	50+ years (Pickart)
Tissue specificity	Systemic (via pineal/epigenetic)	Skin, connective tissue, wound healing
Half-life	~30 min (rapidly cleared)	~30 min free; copper binding extends local activity

Epithalon: Targeting the Root of Cellular Aging

What It Is

Epithalon (Ala-Glu-Asp-Gly, CAS: 307297-39-8) is a synthetic tetrapeptide developed by Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation. It mirrors epithalamin, a natural polypeptide secreted by the pineal gland that declines dramatically with age.

The Telomerase Mechanism

Epithalon's primary documented effect is activation of telomerase — specifically upregulation of hTERT (human telomerase reverse transcriptase), the catalytic subunit:

• Epithalon interacts with DNA regulatory sequences at the hTERT promoter
• This increases hTERT transcription in somatic cells (which normally have suppressed telomerase)
• Active telomerase adds TTAGGG repeats to telomere ends
• Result: Extended proliferative lifespan, delayed entry into replicative senescence

Published in Bulletin of Experimental Biology and Medicine (Khavinson et al., 2003): epithalon treatment of human fetal fibroblasts extended proliferative capacity beyond the Hayflick limit with measurable telomere elongation.

Other Research Areas

• Pineal/Melatonin: Restored nighttime melatonin peaks in aging rodents via AANAT upregulation
• Immune aging: Preserved thymic architecture, maintained naive T-cell output, restored NK cell cytotoxicity
• Longevity: 8-13% mean lifespan extension in rodent models with reduced tumor incidence
• Retinal protection: Preserved photoreceptor function in aging retinal models

GHK-Cu: Gene Expression at Scale

What It Is

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex, CAS: 49557-75-7) is a naturally occurring tripeptide that circulates in human plasma at ~200 ng/mL in young adults — declining to ~80 ng/mL by age 60 (a ~60% reduction). First characterized by Loren Pickart in 1973.

The Gene Modulation Mechanism

GHK-Cu's mechanism is unusually broad. A 2010 Genome Research study (Pickart et al.) using Broad Institute gene chip data found:

• Upregulates 627 genes involved in regeneration and repair
• Downregulates 206 genes associated with inflammation, cancer, and aging
• Net effect: shifts the cellular transcriptome toward a younger, more regenerative state

Key pathways activated:

• Collagen synthesis: Upregulates COL1A1, COL1A2, COL3A1 → increased collagen I and III production
• Angiogenesis: VEGF upregulation → new capillary formation in healing tissue
• Anti-inflammatory: Downregulates TNF-α, IL-6, and NF-κB pathway genes
• Antioxidant: Superoxide dismutase upregulation
• Stem cell activation: Increases expression of stem cell markers in injured tissue

Skin Research Data

GHK-Cu has the most robust skin aging research of any peptide:

• 12-week study: 35% increase in skin density, 120% increase in skin thickness
• Collagen density improved comparable to retinoic acid (without the irritation)
• Wrinkle depth reduced in topical application models

The Stack: Why Researchers Use Both

Epithalon and GHK-Cu address aging at different levels:

• Epithalon works at the cellular lifespan level — extending how long cells can divide before senescence. This is deep, slow-acting biology.
• GHK-Cu works at the tissue maintenance level — actively driving repair, collagen production, and anti-inflammatory signaling right now.

They're not redundant — they're complementary. Epithalon preserves the cellular machinery. GHK-Cu drives that machinery to repair and maintain tissue quality.

The Khavinson longevity stack (as documented in his institute's protocols) explicitly combines both: Epithalon for telomere/systemic aging, GHK-Cu for tissue-level maintenance.

Research Protocol Notes

Epithalon 50mg reconstituted at 1mg/mL (add 50mL BAC water) provides 50 doses at 1mg each. Typical preclinical dosing: 0.1-1mg/kg. Dissolves rapidly due to small molecular weight (~432 Da).

GHK-Cu 50mg reconstituted at 2mg/mL (add 25mL BAC water). Stable for 6-8 weeks refrigerated post-reconstitution. Copper complex is stable at physiological pH.

Both available from Peptides Get Online — research-grade, >98% HPLC purity.